Research Article
Central Infusion of Angiotensin II Type 2 Receptor Agonist Compound 21 Attenuates DOCA/NaCl-Induced Hypertension in Female Rats
Figure 3
Average changes in MAP (a) and HR (b) produced by DOCA/NaCl treatment in intact and OVX female rats. per group; compared to intact or OVX females with central infusion of C21 alone; compared to intact or OVX females with central C21 plus DOCA/NaCl; compared to intact females with DOCA/NaCl.
(a) ā |
(b) |